mobilemenuClose menu

About Pulmonary Fibrosis

Pulmonary Fibrosis (PF) is a progressive, irreversible, chronic disease of the lungs, which currently affects between 80,000 and 111,000 people in Europe. Every year, additional 30,000-35,000 new patients will be diagnosed with IPF.

 

Consultation guide

The EU-IPFF Consultation Guide is a plainly written guide to all the important aspects around IPF and Pulmonary Fibrosis with patient testimonies and expert input from our top experts.

It has been published in six languages.

Please find and download the English version here: Consultation guide

COVID - 19 and Pulmonary Fibrosis

How to protect yourself from COVID-19

COVID-19 is a new illness that can affect your lungs and airways. It is caused by a virus called coronavirus. Anyone can catch COVID-19 if they have been in contact with someone carrying the virus.

Read more

Recommended websites

Trusted online information is often difficult to locate. The EU-IPFF recommends the websites of its members and organisations we have partnered with in the creation of online information resources. We therefore recommend them as additional sources of information

Patient Organisations

Pharma Company Patient Resources

 

EU IPFF

Search